Introduction
Many prescribers rely on websites provided by pharmaceutical companies when searching for treatment information. Consumers also rely heavily on online resources when searching for disease and treatment information. Websites that tailor their site content to address the specific needs of their target audience will experience greater retention of site visitors.
Scope
- Assess and compare the value of leading global pharmaceutical companies’ online presence across a number of criteria
- Identify which tools and services are being used to encourage consumers and healthcare professionals to frequently revisit a website
- Compare the websites of products in the same class to see what gives the leaders a competitive edge
Highlights
Reasons to Purchase
Other selected research from the 'Europe' category:
Website Benchmarking Service: European and US Targeted Websites
Time constraints are limiting the amount of time that physicians and consumers spend to search for information, as well as the amount of time that pharmaceutical companies have to access physicians. As a result, the importance of pharmaceutical websites is growing. This tool looks at the success factors for the physician- and consumer-targeted websites of the top 20 pharmaceutical companies. Learn More
European Healthcare Vertical Market Map 2010
The Healthcare Market Map is a comprehensive interactive model, which assesses and analyses the logistics industry in the key Healthcare sectors across 13 European countries, covering historical, current and forecasted... Learn More
Other selected research from the 'USA' category:
Drug Safety in the Post-Vioxx Era: New legislation, regulation and company strategies in Europe and the US
This report examines the actions taken by legislative and regulatory bodies in response to recent drug safety concerns surrounding the COX-2 inhibitors and antidepressants. Learn More
Website Benchmarking Service - US Consumer Targeted Websites
In contrast to European consumers, US consumers are offered a wide range of choice and information on treatments for specific diseases. Pharmaceutical companies therefore need to reach consumers and provide them with effective information through websites to promote their brand and to capture the attention of consumers. Learn More
Other selected research from the 'IT & eHealth' category:
Stakeholder Opinions: Diabetic Renal Disease
In-depth analysis on the latest challenges, trends and developments in diagnosis, pharmacological and non- pharmacological treatment of Diabetic Renal Disease. Learn More
North American Spending on Electronic Health Records Through 2012 (Databook)
Electronic health records (EHRs) will be the cornerstone of healthcare technology. The design, selection and implementation of EHRs, therefore, will be extremely important for healthcare institutions. Learn More
Other selected research from the 'Pharmacoeconomics' category:
Optimizing Sales Force Effectiveness: Using eHealth Applications to Improve the Quality of Physician Interactions
Gaining access to influential healthcare professionals is difficult because physicians often do not have time to see drug reps during the working day. Furthermore, drug reps often fail to make the most of the limited time they do have with prescribers. Over time this has caused drug reps to lose influence to patient requests during the prescribing process. Learn More
Stakeholder Insight: Neuropathic Pain - Comparative Overview of Treatment Preferences Across the Seven Major Markets
Following the success of Pfizer`s blockbuster Neurontin (gabapentin), interest in the neuropathic pain market has grown exponentially. The market will continue to grow unabated over the next ten years primarily due to increased public and physician awareness and new drug launches, including generic gabapentin. Learn More